Evidence map›Paper›PMID 26982807›Full record

ArticlePloS one2016

Evaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical Outcomes.

Nazaret Cobos-Trigueros, Mar Solé, Pedro Castro, Jorge Luis Torres, Mariano Rinaudo, Elisa De Lazzari, Laura Morata, Cristina Hernández, Sara Fernández, Alex Soriano and 4 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  4. Article
  5. Decalogue for the selection of oral antibiotics for lower respiratory tract infections.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  6. Review
  7. Guidelines for Antibiotic Prescription in Intensive Care Unit.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2019
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nazaret Cobos-TriguerosDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Mar SoléISGlobal, Barcelona Center for International Health Research (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain.
Pedro CastroMedical Intensive Care Unit, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Jorge Luis TorresDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Mariano RinaudoMedical Intensive Care Unit, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Elisa De LazzariHealth Biostatistic, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
Laura MorataDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Cristina HernándezMedical Intensive Care Unit, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Sara FernándezMedical Intensive Care Unit, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Alex SorianoDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
José María NicolásMedical Intensive Care Unit, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Josep MensaDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.
Jordi VilaISGlobal, Barcelona Center for International Health Research (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain.
José Antonio MartínezDepartment of Infectious Diseases, Hospital Clínic, IDIBAPS, Barcelona University, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the effect of two strategies of antibiotic use (mixing vs. cycling) on the acquisition of resistant microorganisms, infections and other clinical outcomes.

methodsProspective cohort study in an 8-bed intensive care unit during 35- months in which a mixing-cycling policy of antipseudomonal beta-lactams (meropenem, ceftazidime/piperacillin-tazobactam) and fluoroquinolones was operative. Nasopharyngeal and rectal swabs and respiratory secretions were obtained within 48h of admission and thrice weekly thereafter. Target microorganisms included methicillin-resistant S. aureus, vancomycin-resistant enterococci, third-generation cephalosporin-resistant Enterobacteriaceae and non-fermenters.

resultsA total of 409 (42%) patients were included in mixing and 560 (58%) in cycling. Exposure to ceftazidime/piperacillin-tazobactam and fluoroquinolones was significantly higher in mixing while exposure to meropenem was higher in cycling, although overall use of antipseudomonals was not significantly different (37.5/100 patient-days vs. 38.1/100 patient-days). There was a barely higher acquisition rate of microorganisms during mixing, but this difference lost its significance when the cases due to an exogenous Burkholderia cepacia outbreak were excluded (19.3% vs. 15.4%, OR 0.8, CI 0.5-1.1). Acquisition of Pseudomonas aeruginosa resistant to the intervention antibiotics or with multiple-drug resistance was similar. There were no significant differences between mixing and cycling in the proportion of patients acquiring any infection (16.6% vs. 14.5%, OR 0.9, CI 0.6-1.2), any infection due to target microorganisms (5.9% vs. 5.2%, OR 0.9, CI 0.5-1.5), length of stay (median 5 d for both groups) or mortality (13.9 vs. 14.3%, OR 1.03, CI 0.7-1.3).

conclusionsA cycling strategy of antibiotic use with a 6-week cycle duration is similar to mixing in terms of acquisition of resistant microorganisms, infections, length of stay and mortality.

Indexed as

Critical IllnessAnti-Bacterial AgentsDrug Resistance, MicrobialHumansTreatment OutcomeAnti-Bacterial Agents

Identifiers

PMID26982807
PMCPMC4794237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.